Literature DB >> 16358521

Killing of animals for disease control purposes.

J W Galvin1, H Blokhuis, M C Chimbombi, D Jong, S Wotton.   

Abstract

In emergency disease outbreaks, large numbers of animals may need to be killed for control, containment and/or eradication purposes. Strategies for disease control will usually involve complete depopulation of herds/flocks, and may extend to depopulation across designated areas. Live animals present the major risk of spreading infectious agents so their slaughter should be completed as quickly as possible, with minimal pain and distress to the animals. The method chosen for killing of animals must be humane, efficient and safe for people and the environment. The tasks should be conducted under the supervision of an official veterinarian, supported by a sufficient number of adequately trained and competent personnel. It is essential to ensure all animals are dead, as demonstrated by the cessation of cardiac and respiratory movements. This paper discusses methods by which animals may be killed for disease control purposes.

Entities:  

Mesh:

Year:  2005        PMID: 16358521

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  3 in total

1.  Concerns on cross-species transmission of SARS-CoV-2 between pets and humans.

Authors:  Xingguang Li; Haizhou Liu; Yigang Tong
Journal:  Front Microbiol       Date:  2022-09-21       Impact factor: 6.064

2.  Emergency euthanasia of cattle challenged with Escherichia coli O157:H7 - a case study for evaluating the response to an infectious disease outbreak.

Authors:  Brandon H Gilroyed; Tim Reuter; John P Kastelic; Tim A McAllister
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

3.  Defining characteristics of immersion carbon dioxide gas for successful euthanasia of neonatal and young broilers.

Authors:  B I Baker; S Torrey; T M Widowski; P V Turner; T D Knezacek; J Nicholds; T G Crowe; K Schwean-Lardner
Journal:  Poult Sci       Date:  2020-06-26       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.